INS and diabetes mellitus: After adjustment for age, duration of diabetes and metformin therapy, baseline BMI and HbA1c as well as a change of weight and HbA1c, multiple linear regression showed that weight loss leads to the longest possible therapeutic success with the combination of metformin and bedtime basal insulin (p < 0.001).